Tag Archives: MTC

PR Newswire

DXY completes USD 500 million financing, to enhance its professional role in healthcare sector

Leave a comment

HANGZHOU, China, Dec. 30, 2020 — On December 28, DXY, a leading digital healthcare technology company in China, announced the completion of a USD 500 million financing. This financing was led by Trustbridge Partners, and followed by Tencent Investment and GL Ventures. Li Tiantian, Founder and Chairman of DXY, said that the company will, driven by both two ends – physicians and the public, strengthen collaboration with professional doctors and enterprises, so as to give play to the expertise of all sides and be a guide for healthy life.

As Chinese people’s awareness of health and consumption rises and changes, the medical and health industry is accelerating its development in the online landscape. In July 2020, DXY released a "dual-core strategy" that connects its brand focusing on the public DX Doctor with its brand targeting physicians DXY.cn, to gather professional strength and offer reliable products. With this financing, DXY plans to keep consolidating its core pillar – physicians’ expertise, supporting the growth of Chinese doctors; and at the meantime, it will reach closer partnership with doctors, enterprises, medical institutions and other professional resources to explore more medical and health scenarios. Through a professional, credible, sustained and holistic portfolio delivered by DX Doctor, the company aspires to improve the quality of Chinese people’s healthy life and fulfill the vision of "MORE HEALTH, BETTER LIFE".

In response to the COVID-19 pandemic, DX Doctor – a platform operated by DXY, took the lead in introducing a COVID-19 Global Pandemic Real-time Report, which has become a major source of global data on the pandemic. Meanwhile, it promptly launched public welfare products such as science popularization and rumors refutation articles, online free consultations, and COVID-19 open classes at both physician and public ends. With these products generating more than 8.6 billion visits/ views, DXY has contributed a lot to the global fight against the novel coronavirus.

PR Newswire

Entain Marks Its First Day With Measures To Deliver On Its New Strategy

Leave a comment

– U.S. growth accelerates as BetMGM plans to double its footprint in three months

– Entain to seek licence in Canada and becomes the first global sports betting and gaming operator to gain a licence in Latin America

LONDON, Dec. 10, 2020 — The global sports betting and gaming group previously known as GVC Holdings plc, marked the first day of trading under its new name with a range of measures to deliver on the vision and direction recently outlined by its CEO Shay Segev. The new measures extend across all the countries in which it operates with brands including bwin, PartyPoker, Ladbrokes, Coral, FoxyBingo and BetMGM.

jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”
 

jwplayer(‘myplayer1’).setup({file: ‘https://mma.prnasia.com/media2/1372389/Entain.mp4?p=medium600’, image: ‘http://www.prnasia.com/video_capture/3218811_AE18811_1.jpg’, autostart:’false’, aspectratio: ’16:9′, stretching : ‘fill’, width: ‘600’, height: ‘338’});

Last month Entain announced a new strategy to deliver significant growth, driven by expansion in the U.S., growth across its core business, entry into new markets, and to new audiences. Entain, which has a very strong track record of 19 consecutive quarters of double-digit growth in its online business, also committed to lead responsible gaming with a new Sustainability Charter. Under this charter, the business pledged to focus only on regulated markets and use its proprietary technology to raise levels of player protection. 

As part of these plans to deliver growth and sustainability, Entain today confirmed strong momentum and market share gains in the U.S. for BetMGM, its joint venture with MGM Resorts. Between October and January BetMGM is adding five new states, doubling its population reach in three months to around 75 million across 12 states. Entain also disclosed that BetMGM’s most recent state launch in Tennessee has been its most successful go-live yet with revenues already ahead of those in more established states. Powered by Entain technology, BetMGM expects to be in over 20 states by the end of 2021.  

"We are firmly on track to take further leadership in the U.S. as well as in many other newly regulated markets that are now opening around the world." said Segev. "At the heart of our growth strategy is a determination to bring the best player experiences and protections to our industry as technology moves sport and interactive entertainment into a new era. In the U.S., we invested in building the right building blocks for the BetMGM platform to grow and become a long-term leader in the U.S., with superior technology and capabilities, and this is now paying off."

Entain also fleshed out its new Sustainability Charter, allocating money to new projects which will be delivered through its international Foundation around the world. It also gave further detail on its new Advanced Responsibility and Care (ARC) initiative, seeking to revolutionise player experiences and protection through world-leading research, data science and technology. Other new measures include:

Focus on new regulated markets: In line with its stated intention to focus on fully regulated markets, Entain today announced it has become the first global sports betting and gaming operator to gain a licence in Latin America and expects to go live in Colombia over the next month. Colombia is one of the first countries to issue licences in Latin America with others, such as Brazil preparing to follow. Elsewhere in the Americas, Canada is also moving ahead with regulation and Entain confirmed it will be applying for licencing in Canada.

  • Investing in people and communities: Entain has pledged to invest £100 million over five years in the Entain Foundation to fund responsible gaming initiatives and to support people and communities around the world where it operates. Today, it announced a series of international commitments: 

    UK: Entain and the three Trident Leagues (The Isthmian, Northern Premier and Southern Leagues) are to launch the Trident Community Foundation to help fund community-based projects. Grants will be open for the 228 football clubs that participate in the leagues.
    "Pitching In", Entain’s recently launched grassroots sport investment programme, is the founding partner of the Trident Community Foundation (TCF) and has donated £150,000 to establish the TCF fund, for distribution over the rest of the 2020/21 season.

    US: The Entain Foundation is rolling out an extensive state-by-state program with EPIC, a charitable organisation which works with former athletes and people who have overcome gambling addiction to help educate people on how to play safely.

    The U.S. project announced today with EPIC extends the program to a total of 15 Pro Sports teams and over 20 colleges across the country, including Harvard University, University of Oregon, and the Mid-American Conference. Entain and EPIC plan to work together to add additional professional sports leagues and colleges across the US during 2021. 

    Germany: The Entain Foundation will continue existing sports integrity projects in Germany and receive early funds to initiate further activities around responsible gaming.

    Australia:  The Foundation has announced initial new projects to advance responsible gaming with Relationships Australia, a community-based not for profit organisation which provides a range of counselling and support services to problem gamblers and their families. The new funding will be used to support a social media campaign to reach vulnerable audiences and to raise awareness of the signs of gambling addiction.

  • Advanced Responsibility and Care (ARC): Under this recently announced programme, Entain will combine its technology with research and insight from leading psychologists and Harvard to develop innovative experiences and safeguards for a new era in interactive sport and entertainment. To this end, Entain today announced that:

    Dr. Michael Auer,     a leading academic and member of the scientific community at the University of Hohenheim in Germany, specialising in behavioural psychology and addiction, will join Entain alongside Professor Mark Griffiths, Distinguished Professor of Behavioral Addiction and Psychology at Nottingham Trent University. They will evaluate and advise on improvements to Entain’s guidelines and processes in relation to responsible gaming.

For more information see the Group’s website: www.entaingroup.com

Video – https://mma.prnasia.com/media2/1372389/Entain.mp4?p=medium600

PR Newswire

YES Partners with Singapore’s Gaia Science

Leave a comment

Specialists in SEA, China science & biotech equipment market to expand YES’s global reach

FREMONT, Calif., Dec. 7, 2020 — YES (Yield Engineering Systems, Inc.), a leading manufacturer of process equipment for semiconductor advanced packaging, Life Science and "More-than-Moore" applications, today announced that it has signed an agreement with Gaia Science Pte. Ltd of Singapore to sell and service YES equipment in southeast Asia and mainland China. 

The partnership, which began in early September, is expected to be particularly helpful in showcasing YES’s monolayer coating and plasma cleaning products to the region’s dynamic Life Science Industries.

"We see considerable synergy between our products and Gaia’s expertise in the areas of microfluidics, engineering polymers, genomics, 3D printing, DNA diagnostics, and oligonucleotides research. That synergy, together with both our companies’ experience in semiconductors, gives us high hopes for this new venture," said Rezwan Lateef, President of YES.

"YES products are well-accepted among the world’s leading Life Science companies, and we look forward to strengthening our relationships with these customers in our region. We see a very good fit for YES products in our portfolio. With our extensive coverage of the Life Science and physical science markets, we expect to leverage the capabilities that YES products bring to both the biotech and semiconductor sectors," said Ms Weng Lijuan, Managing Director at Gaia.

About YES

YES (Yield Engineering Systems, Inc.) is a leading manufacturer of high-tech, cost-effective equipment for transforming surfaces, materials and interfaces.  The company’s product lines include vacuum cure ovens, chemical vapor deposition (CVD) systems, and plasma etching tools used for precise surface modification and thin-film coating of semiconductor wafers, semiconductor and MEMS devices, biosensors and medical substrates. With YES, customers ranging from startups to Fortune 100 companies can create and volume-produce products in a wide range of markets, including Advanced Packaging, MEMS, Augmented Reality/Virtual Reality and Life Sciences. YES is headquartered in Fremont, California, with a growing presence globally. For more information, please visit www.yieldengineering.com.

Media Contact

Victoria Barnes
Director of Communications
YES (Yield Engineering Systems, Inc.)
510-954-6723 direct
VBarnes@yieldengineering.com

About Gaia

Based in Singapore, Gaia Science Pte. Ltd has extensive experience supplying state-of-the-art scientific and laboratory equipment to universities, research institutions and industries. The company is recognized for bringing cutting-edge technologies from its partners and principals to customers working in application areas such as genomics, proteomics, cell biology, animal research, organic synthesis, nanotechnology, clean energy research, environmental analysis, imaging, and education. Besides providing turnkey laboratory solutions to its customers, Gaia Science is also involved with international partners in the design and manufacturing of bioengineering products. For more information, please visit www.gaiascience.com.sg.

Related Links :

home
PR Newswire

PixCell Medical to Enhance NSW Health Pathology’s Point-of-Care Testing Service

Leave a comment

Following TGA approval, NSW Health to Implement PixCell’s HemoScreen™ Device Across Health System

YOKNEAM ILIT, Israel, Dec. 2, 2020 — PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that NSW Health Pathology, the provider of public pathology services for the New South Wales (NSW) government, will deploy PixCell’s HemoScreen™ hematology analyzer for rapid, lab-accurate Complete Blood Count (CBC) testing, accessible at the point of care.

PixCell has worked closely with NSW Health Pathology over the past year to evaluate the HemoScreen™ and they are now in the position to pioneer the use of this innovative POCT technology in facilities across the state.

HemoScreen™ will enable true point-of-care testing (POCT) in terms of operation, electronic result delivery through an Internet of Things approach, ease-of-use, and transportability, while still providing core lab quality results. Outside of Sweden and Denmark, Australia will be the first country to get HemoScreen™ devices, which will soon be implemented throughout NSW.

The collaboration includes the installation of a large number of HemoScreen™ devices that provide the full 5-part differential CBC test with comprehensive abnormal cell flagging. In this initial deployment, NSW Health Pathology will implement HemoScreen™ devices within small labs, in large emergency departments without onsite labs, and to upgrade some existing technology. The devices will then be further assessed for utility in oncology clinics and other settings.

"We recognize the need to simplify real-time blood testing and are proud to work with NSW Health Pathology to increase accessibility to POC diagnostics," said Avishay Bransky, Ph.D., CEO and co-founder of PixCell Medical. "HemoScreen™ delivers accurate readings of 20 standard blood count parameters, which are routinely used to check the overall health status of a patient. The CBC has recently found valid to monitor the severity of COVID-19 and the progression of the disease."

POCD Scientific, boasting over 125 years of experience in the supply and use of scientific equipment and products, will be the sole distributor of HemoScreens for the region of Australia.

This news follows PixCell’s recent approval from the TGA.

About PixCell Medical

PixCell Medical provides the first truly portable point-of-care blood diagnostic solution. Leveraging the company’s patented Viscoelastic Focusing technology, along with AI-powered machine vision, PixCell’s FDA-cleared and CE-approved HemoScreen diagnostic platform shortens diagnostic results delivery from days to minutes. With just one drop of blood and within six minutes, PixCell delivers accurate readings of 20 standard blood count parameters, saving patients, clinicians and health systems significant time and costs.

For more information: www.pixcell-medical.com and follow PixCell on LinkedIn.

Media Contact:
Finn Partners for PixCell Medical
Lior Feigin
lior.feigin@finnpartners.com
@LiorFeigin

PR Newswire

Re-Innovation of Thermal Imaging Technology – FOTRIC Releases Intelligent Thermal Imagers 340A & 340M

Leave a comment

SHANGHAI, Dec. 1, 2020 — Professional thermal imaging brand FOTRIC continues to innovate in technology for users to "enhance efficiency and ensure safety". In August, FOTRIC launched a temperature screening thermal imager for epidemic prevention and maintenance control. Recently, FOTRIC released a breakthrough: intelligent thermal imagers 340A and 340M, which are suitable for industrial equipment maintenance, power and electrical testing, building inspection, etc.

Looking back, FOTRIC has repeatedly achieved successes in product development. In 2017, FOTRIC participated in the USA CES Exhibition and its independently developed products were widely acclaimed. In 2018, FOTRIC won the first place in the electrical application category in the USA IR/INFO Conference. In 2019, FOTRIC’s newly developed product won the 2019 German iF International Industrial Design Award.

AI Boosted Performance

Industrial users are familiar with thermal imagers. However, 340A and 340M are not ordinary models. FOTRIC innovatively fuses AI technology with wisdom and agile genes and brings users an extraordinary intelligent control experience. For example, there is an AI Key supporting programming shortcuts to preset interfaces or functions.


Superior Imaging

"Temperature measurement" and "imaging" are the two core functions of the thermal imager. An easy-to-use thermal imager is inseparable from accurate temperature measurement and high-definition imaging. 340A and 340M are developed based on FOTRIC’s ten years’ solid technology focusing on accurate temperature measurement and thermal imaging. Their temperature measurement stability and consistency have reached the industry-leading level. For imaging, FOTRIC brings a breakthrough innovative technology – "MagicThermal" Multi-color Dynamic. This function allows advanced imaging performance under complex diagnoses and superior in-picture smart isolation of hot-spots for easy live analysis of areas of interest.


TurboFocus on the Go

The 340A model is equipped with an intelligent focusing system "TurboFocus", which realizes fast, accurate, and quiet one-button autofocus. While with the continuous focus function, users do not need to concern about focusing, and can just aim and shoot, which greatly improves the detection efficiency.

At present, FOTRIC seeks partners worldwide to provide local users with customized high-quality services.

About FOTRIC

FOTRIC is the world’s leading provider of precision temperature measurement infrared thermal imaging products and solutions.

Headquartered in Shanghai, China, FOTRIC has distributors in tens of countries and regions including North America, Europe, South Korea, Singapore, Australia, and Taiwan. FOTRIC’s sales network covers multiple fields including power, industry, scientific research, and security.

CONTACT: Celine, nsn@fotric.cn, www.fotric.com 

Related Links :

http://www.fotric.com

PR Newswire

Tony Blair Institute and Oracle Launch Africa Vaccine Management in the Cloud

Leave a comment

The Tony Blair Institute for Global Change and Oracle partner with African governments to manage large-scale vaccination programs in the cloud – over 73,000 people vaccinated and registered in the first 8 days in Ghana

LONDON and REDWOOD SHORES, Calif., Nov. 23, 2020 — The Tony Blair Institute (TBI) and Oracle have brought cloud technology to Africa to manage public health programs. Initially, Ghana, Rwanda, and Sierra Leone will use the new Oracle Health Management System to create electronic health records for their vaccination programs for yellow fever, HPV, polio, measles, and COVID-19, as soon as that vaccine is distributed to Africa. TBI and Oracle are in discussions with more than thirty other countries in Africa, Asia, Europe, and North America that are evaluating using the same cloud system to manage their COVID-19 vaccination programs.  

jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”
 

jwplayer(‘myplayer1’).setup({file: ‘https://www.youtube.com/watch?v=k4oZC3yjolI’, image: ‘http://www.prnasia.com/video_capture/3200226_AE00226_1.jpg’, autostart:’false’, aspectratio: ’16:9′, stretching : ‘fill’, width: ‘600’, height: ‘338’});

"Since February of this year, the Africa Union and Member States have worked tirelessly together to address the impact of COVID-19 on the continent," said Dr. John Nkengasong, Director of the Africa Centres for Disease Control and Prevention. "As the COVID-19 pandemic continues, partnerships such as this one with Oracle, TBI and various governments are critical to the strengthening of Member State public health institutions, not only to incorporate innovative technology but to proactively and urgently harmonize the collection and sharing of important testing data across the continent."

TBI has been providing policy advice and hands-on support to African governments as they tackle complex COVID-19 challenges. To address these challenges, TBI partnered with Oracle to deliver cloud technology to digitize and unify national health data starting with the management of vaccinations. The Oracle Health Management System creates an electronic health record in a cloud database for every person as they are vaccinated. This highly-secure system can be quickly configured to interoperate with each country’s existing technology and meet their most stringent data sovereignty requirements. Participating countries will have access and support for the system, free of charge, for the next ten years.

"This is an immensely exciting and potentially ground-breaking initiative for recording information on all disease vaccinations and treatments in African nations," said Tony Blair, Executive Chairman of TBI and the former Prime Minister of Great Britain and Northern Ireland. "Though Africa has coped well with COVID-19, it still needs to be part of international efforts to control the disease, including for international travel. That means vaccination of at least a significant portion of the population, requiring the highest quality data system so that everyone’s vaccine experience is recorded. Oracle can provide that system with data securely stored and owned by each country and is prepared to do so as part of a global philanthropic partnership.

We will be living with COVID-19 for some years, and the recording of data will be vital in managing its impact and spread. And one thing is clear from this crisis: applying new technology solutions has applications for the digitization of the entire economy and is crucial for the acceleration of African development. This initiative is a great test case, and my Institute is proud to be part of it."  

"The Oracle Health Management System is currently being used by the U.S. government and large healthcare and research organizations to monitor COVID-19 patient symptoms, responses to treatments, and to screen volunteers for COVID-19 vaccine clinical trials," said Oracle Chairman and CTO Larry Ellison. "By working with Tony and his team over a period of a few months, we were able to deliver the exact same 21st century cloud technology to Ghana, Rwanda, and Sierra Leone. This is the first time vaccine data has been stored in a cloud database on a national scale. Africa is leading the way."

Bringing Cloud Technology for Electronic Health Records to Africa

Ghana is now using the system to manage its yellow fever vaccine program and will follow with COVID-19 once that vaccine is distributed in Africa.

Ghana President Nana Akufo-Addo said, "We have learned many lessons from this pandemic. The most obvious is that we have to urgently fortify our public health systems. This strategic partnership with Oracle and TBI is evidence of our drive to digitalize Ghana’s health systems for our people’s benefit."

"The move from Ghana’s current paper-based vaccination campaign records to digital data management using the Oracle platform will enable our data to be easily accessible by authorized persons. The data will be more secure, and there will be no worry about lost cards as people travel," added Dr. Kwame Amponsa-Achiano, Expanded Programme on Immunization, Ghana Health Service.

Hear more from Dr. Kwane Amponsa-Achiano at https://bit.ly/3fntnZf.

Rwanda has prepared its system to support its HPV vaccine administration as soon as secondary schools reopen, with plans to support COVID-19 vaccinations and an immunity pass for citizens in the future.

President of Rwanda, Paul Kagame called for a resilient health system as the best defense against future pandemics: "A COVID-19 vaccine will be a critical tool, and Africa must be able to access to its fair share of a vaccine once it is available. This partnership will deliver an innovative digital vaccine e-registry that signals the continent’s readiness to deploy the vaccine and to safely reopen our economies to trade and tourism."

Sierra Leone is preparing to use the system to create digital vaccination records when its next routine Expanded Program on Immunization (EPI) campaign begins. EPI is a global initiative to vaccinate for polio, diphtheria, tuberculosis, pertussis, measles, and tetanus. It is estimated to prevent two to three million childhood deaths globally each year from these diseases. Sierra Leone’s EPI program reportedly covers 95% of eligible children in that country.

Chief Innovation Officer and Minister of Education of Sierra Leone, Dr. David Moinina Sengeh, noted, "The Government of Sierra Leone is committed to utilizing technology and innovation – digitizing services to improve service delivery for its citizens. Using our experience from Ebola, we were able to put together a robust National COVID-19 Response plan, which has technology, data, and innovation as core enablers. This collaboration with Oracle and TBI is significant not only for dealing with COVID-19 and broader health needs, such as EPI vaccinations but will be a key step in our country’s mission of digitization for all."

As countries begin vaccinating people for COVID-19, the Oracle Health Management System can be used to automatically create an electronic health record for every person vaccinated.  Once the COVID-19 vaccine is available, the Oracle Health Management System will track immunizations and provide recipients with a Digital Quick Response (QR) code. These QR codes will help Africa reopen its borders and economies by providing citizens the proof of immunization needed to move freely for work and travel.

About the Tony Blair Institute for Global Change
TBI’s Government Advisory Practice directly supports leaders in their on-the-ground fight against COVID-19, and our Policy Futures unit is delivering analysis and advice to help countries mitigate economic impact, source essential equipment, harness the power of technology and position themselves for the rebuilding to come.

The tech revolution can be accelerated in Africa and other emerging and developing countries, not only to deal with COVID-19, but also embedding robust health care systems that will benefit citizens, and beyond health, to digitize public services and the economy.

About Oracle
Oracle offers suites of integrated applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at oracle.com.

Boy in Ghana receiving a yellow-fever vaccination. Credit: The Tony Blair Institute for Global Change
Boy in Ghana receiving a yellow-fever vaccination. Credit: The Tony Blair Institute for Global Change

   

Video – https://www.youtube.com/watch?v=k4oZC3yjolI
Photo – https://techent.tv/wp-content/uploads/2020/11/tony-blair-institute-and-oracle-launch-africa-vaccine-management-in-the-cloud-1.jpg
Logo – https://techent.tv/wp-content/uploads/2020/11/tony-blair-institute-and-oracle-launch-africa-vaccine-management-in-the-cloud.jpg

Related Links :

http://www.oracle.com

PR Newswire

Asian Power Devices: Powering modern technology in an ever-shifting landscape

Leave a comment

TAIPEI, Nov. 20, 2020 — Medical field is a critical market for power supplies — APD introduces customized power supply solutions for medical equipment and network equipment. Its systems meet all EMI, temperature, peak load requirements, and company’s Medical Power Supplies protect the PSU from failure resulting from high-frequency 4G/5G signal interference.

APD Medical Power Supply & Lithium-ion UPS Solutions -- Built for the challenges of today
APD Medical Power Supply & Lithium-ion UPS Solutions — Built for the challenges of today

APD Solutions — Built for the challenges of today

This year’s pandemic challenges the current world economic situation and people’s living conditions. Working from home, online meetings, and distance learning has become the new normal. It not only increases the demand for more connected devices and network equipment, but also requires reliable power delivery.

Impact of COVID-19 on healthcare is immediate. Ventilators, oxygen concentrators, and respiratory humidifiers require a lasting, uninterrupted, and stable power supply.

The pandemic is challenging the existing power systems hospitals have relied on. Many healthcare facilities are already at, or beyond maximum capacity, the higher number of patients means more devices and medical systems on the grid.

The toll goes beyond the hospital. Manufacturers are dealing with labor shortages while medical equipment demand has increased. Many factories are speeding up automation, with a growing need for reliable power systems.

Stable and continuous power is paramount for mission-critical medical systems

Corresponds to the products for top-notch care. APD developed dedicated lithium-ion (Li-ion) UPS products to replace the traditional UPS system using lead-acid batteries, bringing multiple benefits for healthcare applications.

Li-ion battery UPS systems have twice the energy density, double the life span, and are smaller and lighter than lead-acid battery-based systems. They offer a significant reduction in maintenance and replacement costs. In the past few years, the technology’s price has dropped substantially. APD’s lithium-ion UPS products use only premium quality protection components that comply with rigorous standards.

Since 1994, Asian Power Devices (APD), with world-class R&D capabilities, highly competitive products and services, has led the power supply market. Current products include power supplies, UPS, and photovoltaic inverters. 

About APD:

When performance and reliability matter, Asian Power Devices is a reliable partner in developing solutions for the medical field. Backed by many years of experience in the industry and insight into market demands, APD provides the most complete power solutions based on customers’ special requirements, and satisfying the diversity & high safety standards of power devices. In short, when performance matters, choose APD.

For more detailed information, please visit the official website: https://www.apd.com.tw/en

Related Links :

首頁

PR Newswire

The fourth CIIE begins taking stall reservations from exhibitors

Leave a comment

SHANGHAI, Nov. 13, 2020 — Some exhibitors planning to attend the fourth China International Import Expo (CIIE) next year started to reserve their stalls on Nov 8. This is the first time that the CIIE has offered such an option.

Five dairy companies – Fonterra, Mille, Ausnutria, Yashily and Saputo – marked their reserved booths on a map of the fourth CIIE.

Companies showcasing products at the beauty makeup section of the Consumer Goods Exhibition Area, pharmaceutical products section of the Medical Equipment & Healthcare Products Exhibition Area, and dairy products section of the Food and Agricultural Exhibition Area will receive priority when reserving their exhibition stalls, as part of new measures adopted by the fourth CIIE.

"We hope to explore a mechanism where exhibitors can choose their preferred stalls on their own starting from next year," said a worker responsible for recruiting exhibitors to the fourth CIIE.

He added that exhibitors can decide earlier to attend the expo and make preparations in advance.

The stalls at the CIIE’s Food and Agricultural Products Area have always proved to be popular among exhibitors wanting to make reservations.

The exhibition area occupied by dairy companies at the third CIIE was nearly 10,000 square meters, with six of the top eight dairy companies in the world taking part in.

The fourth CIIE’s Food and Agricultural Products Area has remained popular, with over 10 dairy companies having signed on to attend and their signed exhibition areas surpassing a total area of 5,000 square meters.

Over 120 beauty makeup and daily chemical companies have been invited to make reservations for exhibition stalls at the fourth CIIE, and many of them are currently signing agreements or making down payments.

Due to high exhibitor demand, the fourth CIIE’s beauty makeup and daily chemical product section is expected to expand to 25,000 square meters from 20,000 sq m this year.

China is the largest and most significant market for Fonterra. The CIIE has provided development opportunities for them, said Han Li, Vice-President of Fonterra Greater China, explaining why they continue to attend the expo and make reservations.

The fourth CIIE began taking applications from business exhibitors on Sept 28. It will set up six business exhibition areas: Intelligent Industry & Information Technology, Consumer Goods, Automobile, Food and Agricultural Products, Medical Equipment & Healthcare Products and Trade in Services.

Contact：Ms. Nie Qingxin

Tel.：0086-21-67008870/67008988

PR Newswire

AlpVision to offer free of charge security feature to protect COVID-19 relevant medicines against counterfeiting

Leave a comment

VEVEY, Switzerland, Nov. 13, 2020 — On November 13th, 2020, AlpVision is launching the "AlpVision COVID-19 Initiative" helping pharmaceutical companies to protect COVID-19 relevant medicines against counterfeiting.

Authentication using smartphones
Authentication using smartphones

COVID-19 has caused not only a worldwide health crisis, but also created unprecedented economic challenges. In response, AlpVision has decided to launch the "AlpVision COVID-19 Initiative". The initiative supports pharmaceutical companies by providing them for free with the necessary tools to protect COVID-19 relevant medicines and vaccines against counterfeiting.

To do so, AlpVision will provide pharmaceutical companies and their suppliers with all necessary tools to deploy the Cryptoglyph on their packaging. The AlpVision Cryptoglyph is a digital security feature which can be implemented and deployed within just a few weeks. The Cryptoglyph is invisible to the human eye and authentication of a product protected with a Cryptoglyph is done using a regular smartphone. Securing of packaging with a Cryptoglyph is very easy as it neither changes the standard production process, nor requires additional consumables. In addition, the smartphone applications connect to AlpVision’s Brand Monitoring System (BMS), a centralized server platform through which pharmaceutical companies are able to monitor in real-time product authentication activities and gain important insight into counterfeiting activities.

The "AlpVision COVID-19 Initiative" starts on November 13th, 2020, and subscription will run for an initial period of three months. Participating companies will be able to protect their COVID-19 relevant products with zero additional cost for the authentication feature. AlpVision will provide this service gratuitously until the pandemic is officially declared as ended by the World Health Organization. Companies interested in participating in the initiative are invited to contact AlpVision. More information can be found online at www.alpvision.com/Covid/.

ALPVISION – MORE THAN ANTI-COUNTERFEIT SOLUTIONS

AlpVision was founded in 2001 and is the world’s leader in digital anti-counterfeiting technologies for product authentication and counterfeit protection. AlpVision’s digital anti-counterfeiting solutions for product authentication are applicable to a wide variety of items, including packaging and labelling, plastic and metal products, and high-value documents. AlpVision anti-counterfeiting solutions are commercialized worldwide under license agreements as entirely customizable turnkey computerized systems. Today AlpVision protects over 30 billion of products each year. More information is available at www.alpvision.com. Join us on LinkedIn and follow us on Twitter.

Cryptoglyph and AlpVision are registered trademarks of AlpVision SA. Smart Embossing, AlpVision Fingerprint® and Krypsos are trademarks of AlpVision SA.

Contact:

Martin Kutter 
+41 21 948 6464  
avinfo-20@alpvision.com

Photo – https://techent.tv/wp-content/uploads/2020/11/alpvision-to-offer-free-of-charge-security-feature-to-protect-covid-19-relevant-medicines-against-counterfeiting.jpg
Logo – https://techent.tv/wp-content/uploads/2020/11/alpvision-to-offer-free-of-charge-security-feature-to-protect-covid-19-relevant-medicines-against-counterfeiting-2.jpg

  

Related Links :

http://www.alpvision.com

PR Newswire

Integrating Fitbit Wearable Devices into Diabetes Care Leads to Significant Improvements in Blood Glucose and HbA1C, Finds Health2Sync Clinical Study in Taiwan

Leave a comment
  • Wearing Fitbit devices with Health2Sync glucose control app clinically proven to help both users and healthcare providers to control and better manage the symptoms of Type 2 diabetes
  • Results from the study in Taiwan revealed an improvement in patients’ health conditions, with participants recording higher levels of physical activity, reduced HbA1C, fasting blood glucose and LDL-C, and higher blood glucose measurement frequency
  • The Health2Sync Patient Management Platform allows healthcare providers to seamlessly monitor patients’ information and provide remote consultative advice where necessary

SINGAPORE, Nov. 13, 2020 — Health2Sync, the number one diabetes management app in Taiwan and Japan, today announced the results of their clinical study in Taiwan, demonstrating that combining Fitbit wearable devices with their Health2Sync Patient Management Platform can help users control and better manage the symptoms of Type 2 diabetes mellitus (T2DM). In the study[1], conducted with four of Taiwan’s leading diabetes clinics, participants recorded significant average improvements in key indicators, such as reduced HbA1C, fasting blood glucose  and LDL-C, and higher blood glucose measurement frequency — a valuable proof of concept for using Fitbit wearables with diabetes care protocols and solutions.     

Voluntarily connecting their Fitbit Inspire HR with the Health2Sync App enabled study participants to let their doctors seamlessly monitor their information on the Health2Sync Patient Management Platform and provide remote consultative advice where necessary.
Voluntarily connecting their Fitbit Inspire HR with the Health2Sync App enabled study participants to let their doctors seamlessly monitor their information on the Health2Sync Patient Management Platform and provide remote consultative advice where necessary.

The study found:

  • Average glycated haemoglobin (HbA1C) decreased 0.33%, while patients who did moderate to high-intensity activity duration of at least 150 mins per week, saw their average HbA1C[2] decrease 0.66%
  • Average fasting blood glucose (BG) decreased 10.92 mg/dL
  • Average low-density lipoprotein cholesterol (LDL-C) decreased 11.55 mg/dL
  • Weight reduction of up to 2 kilograms among some patients
  • Increased frequency in moderate to high intensity activity to 7.03 times a week among some patients

Conducted over a three-month period ending in July 2020 in conjunction with the Neng-Chun Diabetes Clinic, Da-Ya Chang-An Clinic, Yier Clinic and Banqiao Da-Jun Clinic, the study, with patient consent, lets the patients’ doctors track the progress and lifestyle changes of 95 participants with T2DM. Prior to the commencement of the study, doctors at the four clinics established benchmarks for all participating patients based on blood glucose tests at the start of the trial, then on a self-monitored weekly basis throughout the study period.

Each participant was given a Fitbit Inspire HR and the participants voluntarily agreed to connect their Fitbit wearable data with the Health2Sync diabetes management app to track their progress throughout the program. Physical activity data generated from each person’s Fitbit device was integrated into the Health2Sync app, which housed other health metrics such as patients’ HbA1c, BG and cholesterol levels. This let doctors seamlessly monitor patients’ information on the Health2Sync Patient Management Platform and provide remote consultative advice where necessary.

Dr. Kuo-Liang Lu of Da-Ya Chang-An Clinic in Taiwan, said: "The results speak for themselves. We saw a reduction in some of our patients’ weight by an average of two kilograms and fasting BG levels of study participants from Da-Ya Chang-An clinic decreased 11.10 mg/dL within 3 months[3], leading to significant health improvements."

Dr. Neng-Chu Yu of Neng-Chun Diabetes Clinic said: "Type 2 diabetes, with the right lifestyle changes – medication adherence, increased activity, and better diet – can lead to major improvements in control of blood glucose levels. The integration of Fitbit data with Health2Sync let me easily view my patients’ activities and self-monitored data, enabling me to make necessary suggestions and give guidance to help patients for further improvement."

Diabetes is a chronic condition that, if not managed, can lead to health complications like blindness, kidney failure, heart attacks, stroke and lower limb amputation.[4] It remains the second highest cause in premature mortality, after cancer, among major non-communicable diseases in Taiwan[5] and its prevalence has posed economic burdens such as increased personal and healthcare spending and loss of work productivity.[6]

A holistic approach to managing T2DM requires lifestyle changes, which includes medication adherence, exercise and proper diet. The integration with Fitbit wearable devices and activity data is key to helping to promote healthier behaviours and improve participants’ health outcomes. Participants received reminders for weekly exercises via their Health2Sync App, which promoted an increased frequency in moderate to high intensity activity at 7.03 times a week. The increased levels of activity corresponded with an improvement in patients’ health conditions.

"We are thrilled to see such optimistic results in the clinical study. We believe that innovations in Fitbit wearable devices and Fitbit health solutions have a major role to play in the global effort against diabetes – whether it is in reducing the onset of diabetes, or helping patients to better manage their condition – and we look forward to further expanding on our partnership with Fitbit," said Ed Deng, CEO at Health2Sync.

"The behavioural changes exhibited by study participants reinforces our belief that Fitbit amplifies our intrinsic motivation to adopt healthier habits, which can make all the difference when dealing with a condition like Type 2 diabetes where lifestyle factors play such a big role," said Steve Morley, Vice President of International Health Solutions & General Manager of Asia Pacific at Fitbit. "Together with the seamless experience that Health2Sync provides for patients and their health providers to track key indicators, they create a powerful solution that makes it simpler and more convenient to manage conditions like Type 2 diabetes."

In September last year, Fitbit and Health2Sync collaborated to allow the integration of Fitbit’s health, sleep and fitness wearable data with the Health2Sync app (with user consent) to support Health2Sync’s 520,000 users in Japan and Taiwan to better manage their conditions, like Type 2 diabetes. The new platform gives users who have a Fitbit account access to an in-app dashboard that includes the option to agree to share their wearable data from their Fitbit devices[7], including heart rate, sleep and physical activity, alongside recent blood glucose readings from Health2Sync depicting if levels fall within, above, or below the healthy range.

[1] The study was conducted on 95 participants, ages 18- 60.

[2] The term HbA1c refers to glycated haemoglobin. Diabetics with higher levels of HbA1c face greater risk of developing diabetes-related complications.

[3] Average fasting blood glucose levels of study participants from Da-Ya Chang-An clinic decreased 11.10 mg/dL compared to the study average of 10.92 mg/dL

[4] "Diabetes" World Health Organization, 2020. https://www.who.int/news-room/fact-sheets/detail/diabetes.

[5] IC Chen., Yu NC. "A Decade of Diabetes Care in Taiwan." Diabetes research and clinical practice. U.S. National Library of Medicine, 2014. https://pubmed.ncbi.nlm.nih.gov/25550058/.

[6] Wong LC., Tsai CY., Chou HK., Tsai MT., Tsai WH., Chou.P., and Shen ST. "Healthcare costs associated with progressive diabetic retinopathy among National Health Insurance enrollees in Taiwan, 2000-2004." BMC Health Services Research, May 26, 2010. https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-10-136

[7] Includes Fitbit Sense, Fitbit Versa 3, Fitbit Charge 4, Fitbit Inspire 2, among others.

About Health2Sync

Health2Sync scales diabetes care by providing a digital engagement platform that is comprised of a mobile App for diabetics, cloud-based analytics, and cloud platform for healthcare providers. The smart analytics algorithms provide users with personalized education and guidance based on their biometric and behavior data captured. With the cloud platform, healthcare providers can easily take control of patients’ condition through the analyzed data.

Health2Sync is the largest diabetes management platform in Asia (excl. China) and proven to help users improve their outcome.  Health2Sync has supported partners including pharmaceuticals, private payers, and the public payor to provide diabetics with innovative services.  In 2017, 2018 and 2019 Health2Sync was selected as Top 10 Diabetes App globally by Healthline.